STUDY OF METHODS FOR CONVERTING RAMOPLANINA INTO THE NAI-603 SEMI-SYNTHETIC DERIVATIVE (Q2044180): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Changed an Item) |
||
| Property / programme | |||
| Property / programme: Lombardia - ERDF / rank | |||
Normal rank | |||
Revision as of 06:58, 24 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | STUDY OF METHODS FOR CONVERTING RAMOPLANINA INTO THE NAI-603 SEMI-SYNTHETIC DERIVATIVE |
Project in Italy financed by DG Regio |
Statements
12,500.0 Euro
0 references
25,000.0 Euro
0 references
50.0 percent
0 references
30 January 2018
0 references
29 September 2018
0 references
30 December 2018
0 references
NAICONS S.R.L.
0 references
45°28'0.48"N, 9°11'25.80"E
0 references
LA RAMOPLANINA E UN ANTIBIOTICO DI ORIGINE NATURALE CON ATTIVITA MOLTO POTENTE NEI CONFRONTI DI PATOGENI GRAM-POSITIVI MULTI-RESISTENTI. TUTTAVIA, LA RAMOPLANINA NON E UTILIZZABILE COME FARMACO SISTEMICO PER IL TRATTAMENTO DI GRAVI INFEZIONI OSPEDALIERE, IN QUANTO NON E LOCALMENTE TOLLERATA. TUTTAVIA, E STATO POSSIBILE OTTENERE UN DERIVATO SEMI-SINTETICO, DENOMINATO NAI-603, CHE POSSIEDE LE STESSE CARATTERISTICHE ANTIBATTERICHE E FARMACOLOGICHE DI RAMOPLANINA (SPETTRO ANTIBATTERICO, ATTIVI (Italian)
0 references
Identifiers
E47H18000630007
0 references